Fig. 6From: Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosisCombinated effect of raltitrexed and anlotinib on gene transcription in ESCC cells. mRNA levels of Bcl-2, MMP-9, Bax and Caspase-3 were measured by qPCR in either KYSE-30 (A-D) or TE-1 (E-H) cells after treated by 20 μM anlotinib, 2.5 μM raltitrexed, or both. Data indicate means + SD of three biological replicates. Student’s t test; *P < 0.05, **P < 0.01, ***P < 0.01 (versus control); ##P < 0.01, ###P < 0.001 (versus 20 μM anlotinib or 2.5 μM raltitrexed)Back to article page